WHC is still in active development. Read this to understand our approach.
depiction of UWJUQVWARXYRCG-UHFFFAOYSA-N.svg
tripsit

o-desmethyltramadol

Verificar en tripsit

psychonaut

O-Desmethyltramadol

Verificar en psychonaut

isomerdesign

O-Desmethyltramadol

Verificar en isomerdesign

druglab

O-Desméthyltramadol

Verificar en druglab

drugmap

O-DESMETHYL TRAMADOL

Verificar en drugmap

wiki

Desmetramadol

Verificar en wiki

Data

InChI: InChI=1S/C15H23NO2/c1-16(2)11-13-6-3-4-9-15(13,18)12-7-5-8-14(17)10-12/h5,7-8,10,13,17-18H,3-4,6,9,11H2,1-2H3

Sinónimos: CHEMBL201556,TRAMADOL HYDROCHLORIDE IMPURITY D [EP IMPURITY], BDBM50176258, (-)-O-Desmethyl Tramadol, CTK8E8372,Q63395330,UNII-9W28LW2ET5, 80456-81-1,80456-81-1,Mono-O-demethyltramadol,RAC-3-((1R,2R)-2-((DIMETHYLAMINO)METHYL)-1-HYDROXYCYCLOHEXYL)PHENOLC,UNII-2WA8F50C3F,3-{(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl}phenol,Desmetramadol, R,R-(+)-,PHENOL, 3-((1R,2R)-2-((DIMETHYLAMINO)METHYL)-1-HYDROXYCYCLOHEXYL)-, REL-,Desmetramadol, cis-(+)-, O-DESMETHYL TRAMADOL, BDBM50176263, SCHEMBL2517055,AKOS030241093,(RR,SS)-3-(2-((DIMETHYLAMINO)METHYL)-1-HYDROXYCYCLOHEXYL)PHENOL, O-Demethyl tramadol, ZINC2509756,9W28LW2ET5,(+)-O-Desmethyltramadol,o-dsmt, Mono-O-demethyltramadol, 3-{(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl}phenol,2WA8F50C3F,3-[(1R,2R)-2-[(DIMETHYLAMINO)METHYL]-1-HYDROXYCYCLOHEXYL]PHENOL,tramadol M1 metabolite,Desmetramadol,CHEMBL1400,3-((1R,2R)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol, CHEMBL1400, UWJUQVWARXYRCG-HIFRSBDPSA-N,NCGC00165941-01,O-DESMETHYL TRAMADOL,DTXSID901313651, tramadol M1 metabolite, 3-((1R,2R)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol,3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxy-cyclohexyl]phenol, CHEMBL201556,SCHEMBL2517055,DTXSID401044548,Phenol, 3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-, cis-(+/-)-,O-Desmethyltramadol,CHEBI:165221,80456-81-1 (free base),DESMETRAMADOL [INN],O-DSMT,144830-14-8,Phenol, 3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-, (1R-cis)-, Phenol, 3-(2-((dimethylamino)me,BDBM50176258,BDBM50176263, 2-[(Dimethylamino)methyl]-1-(3-hydroxyphenyl)cyclohexanol, 144830-15-9,DESMETRAMADOL [WHO-DD], (+)-O-Desmethyltramadol,o-smt,odt,rel-3-((1R,2R)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol,Phenol, 3-((1R,2R)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-,(+)-O-Demethyltramadol

Estimated data

Solubilidad: -1.707 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 68.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.